[Management of acute coronary syndrome]

Maria Buske1, Hans-Josef Feistritzer1, Alexander Jobs1

  • 1Herzzentrum Leipzig, Universitätsklinik für Kardiologie, Strümpellstr. 39, 04289, Leipzig, Deutschland.

Herz
|January 10, 2025
PubMed

Insights

Acute coronary syndrome (ACS) requires prompt evaluation including troponin testing for timely treatment. Secondary prevention of coronary artery disease (CAD) involves tailored medications and patient education for risk management.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Coronary artery disease (CAD) is a leading global cause of mortality.
  • Acute coronary syndrome (ACS) is often the initial presentation of CAD.
  • Timely diagnosis and risk-adapted treatment are critical for ACS patients.

Purpose of the Study:

  • To outline the essential components of timely and comprehensive assessment for Acute Coronary Syndrome (ACS).
  • To emphasize the importance of risk-adapted treatment strategies for secondary prevention in Coronary Artery Disease (CAD).

Main Methods:

  • Clinical presentation evaluation
  • Electrocardiogram (ECG) analysis
  • High-sensitivity cardiac troponin laboratory diagnostics
  • Risk stratification for treatment planning

Main Results:

  • Prompt assessment integrating clinical, ECG, and troponin data facilitates immediate or early invasive coronary angiography.
  • Revascularization, antithrombotic therapy, and lipid-lowering treatments are key for secondary CAD prevention.
  • Individualized treatment duration and medication choice based on patient risk profile are crucial.

Conclusions:

  • A systematic approach to ACS diagnosis and treatment is vital.
  • Personalized secondary prevention strategies, including medication and patient education, are essential for managing CAD.
  • Effective risk factor management improves long-term outcomes for CAD patients.

Related Concept Videos

Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
452
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
517
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
636
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
72